Filing Details
Alkermes plc. (NASDAQ:ALKS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 28, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:ALKS
Alkermes plc. (ALKS) Files Quarterly Report for Q0
Filing Details Alkermes plc. (NASDAQ:ALKS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 28, 2026. The Healthcare company reported Q0…
Market Context
Alkermes plc.'s stock currently trades at $50.50 with a market capitalization of $5.0B.
The 10-Q provides Alkermes plc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Alkermes plc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ALKS Stock Page
Frequently Asked Questions
Where can I read ALKS's SEC filings?
Browse all filings on our ALKS SEC filings page.
What types of SEC filings does Alkermes plc. file?
Public companies like Alkermes plc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.